2-230996244-T-C

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_139073.5(SPATA3):​c.11T>C​(p.Val4Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000071 in 1,548,588 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000033 ( 0 hom., cov: 29)
Exomes 𝑓: 0.0000043 ( 0 hom. )

Consequence

SPATA3
NM_139073.5 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.748

Publications

0 publications found
Variant links:
Genes affected
SPATA3 (HGNC:17884): (spermatogenesis associated 3) Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]
SPATA3-AS1 (HGNC:28013): (SPATA3 antisense RNA 1 (head to head))

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.03951767).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SPATA3NM_139073.5 linkc.11T>C p.Val4Ala missense_variant Exon 1 of 5 ENST00000433428.7 NP_620712.2 Q8NHX4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SPATA3ENST00000433428.7 linkc.11T>C p.Val4Ala missense_variant Exon 1 of 5 1 NM_139073.5 ENSP00000403804.2 Q8NHX4

Frequencies

GnomAD3 genomes
AF:
0.0000334
AC:
5
AN:
149726
Hom.:
0
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.000123
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000191
AC:
3
AN:
156902
AF XY:
0.0000242
show subpopulations
Gnomad AFR exome
AF:
0.000365
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000429
AC:
6
AN:
1398862
Hom.:
0
Cov.:
32
AF XY:
0.00000725
AC XY:
5
AN XY:
689898
show subpopulations
African (AFR)
AF:
0.000190
AC:
6
AN:
31572
American (AMR)
AF:
0.00
AC:
0
AN:
35552
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25100
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35728
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79174
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49220
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5700
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1078694
Other (OTH)
AF:
0.00
AC:
0
AN:
58122
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000334
AC:
5
AN:
149726
Hom.:
0
Cov.:
29
AF XY:
0.0000274
AC XY:
2
AN XY:
72994
show subpopulations
African (AFR)
AF:
0.000123
AC:
5
AN:
40502
American (AMR)
AF:
0.00
AC:
0
AN:
15056
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3440
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5050
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4714
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10346
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67348
Other (OTH)
AF:
0.00
AC:
0
AN:
2056
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.545
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000106
Hom.:
0

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jul 14, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.11T>C (p.V4A) alteration is located in exon 1 (coding exon 1) of the SPATA3 gene. This alteration results from a T to C substitution at nucleotide position 11, causing the valine (V) at amino acid position 4 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.36
BayesDel_addAF
Benign
-0.47
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
11
DANN
Benign
0.69
DEOGEN2
Benign
0.0032
T;T;T;.;T
Eigen
Benign
-0.64
Eigen_PC
Benign
-0.63
FATHMM_MKL
Benign
0.54
D
LIST_S2
Benign
0.38
.;.;.;T;T
M_CAP
Benign
0.0021
T
MetaRNN
Benign
0.040
T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.69
N;N;N;.;N
PhyloP100
0.75
PrimateAI
Benign
0.41
T
PROVEAN
Benign
-0.53
N;N;N;.;N
REVEL
Benign
0.037
Sift
Benign
1.0
T;T;T;.;T
Sift4G
Benign
1.0
T;T;T;T;T
Vest4
0.11
MVP
0.12
ClinPred
0.033
T
GERP RS
0.48
PromoterAI
0.035
Neutral
Varity_R
0.036
gMVP
0.083
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs955559993; hg19: chr2-231860959; API